RT Journal Article
SR Electronic
T1 Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004338
DO 10.1136/jitc-2021-004338
VO 10
IS 5
A1 Wei, Wei
A1 Ban, Xiaohua
A1 Yang, Fan
A1 Li, Jibin
A1 Cheng, Xiaqin
A1 Zhang, Rong
A1 Huang, Xin
A1 Huang, Yongwen
A1 Li, Qiaqia
A1 Qiu, Ya
A1 Zheng, Min
A1 Zhu, Xiaofeng
A1 Li, Jundong
YR 2022
UL http://jitc.bmj.com/content/10/5/e004338.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.